Global Fund to Acquire Breakthrough HIV Injectable Vaccine for Poor Countries
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed an access agreement with Pharmaceutical Company Gilead
-
+256 414 234 230/50
-
sanyu@sanyufm.com
-
6th Floor Crane Chambers. Plot No.38 Kampala Road. P.O. Box 7781
Kampala,Uganda.
Studio Lines
